Holland, PA, United States of America

Eugene S Gutman

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Eugene S. Gutman

Introduction

Eugene S. Gutman is a notable inventor based in Holland, PA (US). He has made significant contributions to the field of pain management through his innovative research and development of pharmaceutical compounds. His work focuses on creating improved medications to treat chronic and acute pain.

Latest Patents

Eugene S. Gutman holds a patent for "Biased potent opioid-like agonists as improved medications to treat chronic and acute pain and methods of using the same." This invention is directed to a compound having a specific formula and its enantiomer, with detailed definitions provided in the disclosure. The patent also encompasses pharmaceutical compositions of the disclosed compounds, as well as their application as opioid-like agonists in pain treatment. He has 1 patent to his name.

Career Highlights

Eugene S. Gutman works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His role involves significant research and development efforts aimed at enhancing pain management therapies.

Collaborations

Some of his notable coworkers include Eric W. Bow and Kenner C. Rice. Their collaborative efforts contribute to the advancement of innovative solutions in the field of pain management.

Conclusion

Eugene S. Gutman's work exemplifies the importance of innovation in healthcare, particularly in the development of effective pain management therapies. His contributions continue to impact the medical community positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…